BlackRock Health Sciences Trust
BME
$44.49
-$0.01-0.02%
| Weiss Ratings | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BlackRock | |||
| Manager/Tenure (Years) | Erin Xie (21), Kyle McClements (14), Christopher M. Accettella (13), 1 other | |||
| Website | http://www.blackrock.com | |||
| Fund Information | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BlackRock Health Sciences Trust | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Mar 28, 2005 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.26% | |||
| Dividend | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.33% | |||
| Asset Allocation | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 3.35% | |||
| Stock | 96.48% | |||
| U.S. Stock | 92.41% | |||
| Non-U.S. Stock | 4.07% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.01% | |||
| Convertible | 0.00% | |||
| Other Net | 0.16% | |||
| Price History | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.16% | |||
| 30-Day Total Return | -0.11% | |||
| 60-Day Total Return | 5.22% | |||
| 90-Day Total Return | 13.19% | |||
| Year to Date Total Return | 9.98% | |||
| 1-Year Total Return | 23.97% | |||
| 2-Year Total Return | 16.97% | |||
| 3-Year Total Return | 35.43% | |||
| 5-Year Total Return | 32.90% | |||
| Price | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | $43.98 | |||
| 1-Month High Price | $46.28 | |||
| 52-Week Low Price | $36.05 | |||
| 52-Week Low Price (Date) | Sep 25, 2025 | |||
| 52-Week High Price | $46.28 | |||
| 52-Week High Price (Date) | Aug 26, 2026 | |||
| NAV | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $45.57 | |||
| 1-Month Low NAV | $45.00 | |||
| 1-Month High NAV | $48.03 | |||
| 52-Week Low NAV | $39.12 | |||
| 52-Week Low NAV (Date) | Sep 25, 2025 | |||
| 52-Week High NAV | $48.03 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | 12.56 | |||
| Balance Sheet | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 599.29M | |||
| Operating Ratios | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.10% | |||
| Turnover Ratio | 54.00% | |||
| Performance | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 17.19% | |||
| Last Bear Market Total Return | -5.52% | |||